Clinical Trial Update: Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating ISA247 (voclosporin) against placebo and ciclosporin in plaque psoriasis has completed. The study is sponsored by Aurinia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Ciclosporin (cyclosporine)
• ISA247 (voclosporin)

Snippet

Sponsor: Aurinia Pharmaceuticals Inc. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED